(a) A manufacturer of an investigational drug, biological product or device may make the drug, product or device available to eligible patients in accordance with the provisions of this section. Nothing in this section shall be construed to require a manufacturer to make available any drug, product or device.
(b) A health care insurer may, but is not required to, provide coverage for the cost of an investigational drug, biological product or device.
(c) Nothing in this section expands the coverage provided in W.S. 26-20-301.